FDA Lands Califf As Top Deputy, Potential Next Commissioner
This article was originally published in The Tan Sheet
Executive Summary
Renowned cardiologist and clinical trial researcher Robert Califf will join FDA in February as deputy commissioner for medical products and tobacco. Califf is director of Duke University’s Translational Medicine Institute and vice chancellor for Clinical and Translational Research.
You may also be interested in...
Gottlieb's Short Tenure Will Be Felt Long After He Leaves US FDA
Commissioner Scott Gottlieb will leave FDA less than two years after his confirmation, but will exit with a substantial list of accomplishments for industry and patients.
Gottlieb's Short Tenure Will Be Felt Long After He Leaves US FDA
Commissioner Scott Gottlieb will leave FDA less than two years after his confirmation, but will exit with a substantial list of accomplishments for industry and patients.
Scott Gottlieb Calls It Quits After An Active Tenure At US FDA
The commissioner says he will step down next month, leaving a legacy of active policy development, but also a lot of initiatives and pilot projects that are in the middle of being implemented.